375 related articles for article (PubMed ID: 36600151)
1. The genomic regulation of metastatic dormancy.
Gelman IH
Cancer Metastasis Rev; 2023 Mar; 42(1):255-276. PubMed ID: 36600151
[TBL] [Abstract][Full Text] [Related]
2. Micrometastatic disease and metastatic outgrowth: clinical issues and experimental approaches.
McGowan PM; Kirstein JM; Chambers AF
Future Oncol; 2009 Sep; 5(7):1083-98. PubMed ID: 19792975
[TBL] [Abstract][Full Text] [Related]
3. Unveiling cancer dormancy: Intrinsic mechanisms and extrinsic forces.
Liu R; Zhao Y; Su S; Kwabil A; Njoku PC; Yu H; Li X
Cancer Lett; 2024 Jun; 591():216899. PubMed ID: 38649107
[TBL] [Abstract][Full Text] [Related]
4. The Relationship Between Dormant Cancer Cells and Their Microenvironment.
Linde N; Fluegen G; Aguirre-Ghiso JA
Adv Cancer Res; 2016; 132():45-71. PubMed ID: 27613129
[TBL] [Abstract][Full Text] [Related]
5. Dormancy and cancer stem cells: An enigma for cancer therapeutic targeting.
Talukdar S; Bhoopathi P; Emdad L; Das S; Sarkar D; Fisher PB
Adv Cancer Res; 2019; 141():43-84. PubMed ID: 30691685
[TBL] [Abstract][Full Text] [Related]
6. Myeloid derived suppressor cells and the release of micro-metastases from dormancy.
Khadge S; Cole K; Talmadge JE
Clin Exp Metastasis; 2021 Jun; 38(3):279-293. PubMed ID: 34014424
[TBL] [Abstract][Full Text] [Related]
7. An in vitro system to study tumor dormancy and the switch to metastatic growth.
Barkan D; Green JE
J Vis Exp; 2011 Aug; (54):. PubMed ID: 21860375
[TBL] [Abstract][Full Text] [Related]
8. Dormancy in the Tumor Microenvironment.
Omokehinde T; Johnson RW
Adv Exp Med Biol; 2021; 1329():35-49. PubMed ID: 34664232
[TBL] [Abstract][Full Text] [Related]
9. Tumor dormancy and cancer stem cells: two sides of the same coin?
Kleffel S; Schatton T
Adv Exp Med Biol; 2013; 734():145-79. PubMed ID: 23143979
[TBL] [Abstract][Full Text] [Related]
10. KISS1 metastasis suppressor in tumor dormancy: a potential therapeutic target for metastatic cancers?
Harihar S; Welch DR
Cancer Metastasis Rev; 2023 Mar; 42(1):183-196. PubMed ID: 36720764
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic plasticity in metastatic dormancy: mechanisms and therapeutic implications.
Robinson NJ; Parker KA; Schiemann WP
Ann Transl Med; 2020 Jul; 8(14):903. PubMed ID: 32793747
[TBL] [Abstract][Full Text] [Related]
12. Molecular mechanisms underlying tumor dormancy.
Almog N
Cancer Lett; 2010 Aug; 294(2):139-46. PubMed ID: 20363069
[TBL] [Abstract][Full Text] [Related]
13. Cell dormancy and tumor refractory.
Wang K; Jiang W; Cheng C; Li Y; Tu M
Anticancer Agents Med Chem; 2013 Feb; 13(2):1312-1316. PubMed ID: 22934702
[TBL] [Abstract][Full Text] [Related]
14. Dormancy in cancer.
Endo H; Inoue M
Cancer Sci; 2019 Feb; 110(2):474-480. PubMed ID: 30575231
[TBL] [Abstract][Full Text] [Related]
15. Metastatic Cell Dormancy and Re-activation: An Overview on Series of Molecular Events Critical for Cancer Relapse.
Muzes G; Sipos F
Anticancer Agents Med Chem; 2017; 17(4):472-482. PubMed ID: 27592547
[TBL] [Abstract][Full Text] [Related]
16. An in vitro hyaluronic acid hydrogel based platform to model dormancy in brain metastatic breast cancer cells.
Narkhede AA; Crenshaw JH; Crossman DK; Shevde LA; Rao SS
Acta Biomater; 2020 Apr; 107():65-77. PubMed ID: 32119920
[TBL] [Abstract][Full Text] [Related]
17. Regulation of Metastatic Tumor Dormancy and Emerging Opportunities for Therapeutic Intervention.
Tamamouna V; Pavlou E; Neophytou CM; Papageorgis P; Costeas P
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430404
[TBL] [Abstract][Full Text] [Related]
18. The Role of the Innate Immune System in Cancer Dormancy and Relapse.
Chernosky NM; Tamagno I
Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830776
[TBL] [Abstract][Full Text] [Related]
19. Tumor dormancy as an alternative step in the development of chemoresistance and metastasis - clinical implications.
Rossari F; Zucchinetti C; Buda G; Orciuolo E
Cell Oncol (Dordr); 2020 Apr; 43(2):155-176. PubMed ID: 31392521
[TBL] [Abstract][Full Text] [Related]
20. Systems biology of tumor dormancy: linking biology and mathematics on multiple scales to improve cancer therapy.
Enderling H; Hahnfeldt P; Hlatky L; Almog N
Cancer Res; 2012 May; 72(9):2172-5. PubMed ID: 22414579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
